<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Nature Network - clinical trials</title>
    <description>The latest taggings for clinical trials</description>
    <link>http://network.nature.com/announcements</link>
    <language>en-us</language>
    <ttl>40</ttl>
    <item>
      <title>Christopher Scott</title>
      <description>
        <![CDATA[Christopher Scott - ]]>
      </description>
    </item>
    <item>
      <title>Reporting medicine in the media</title>
      <description>
        <![CDATA[Helen Jaques - "Four daily cups of tea 'prevents heart attacks'":http://www.dailymail.co.uk/health/article-1025630/Four-daily-cups-tea-prevents-heart-attacks.html? "Alcohol can cut risk of arthritis":http://www.guardian.co.uk/society/2008/jun/05/drugsandalcohol.health? Hmm, far-fetched sounding stories on medical research pop up in the news all the time. However, the other day I stumbled across the fantastic NHS website]]>
      </description>
    </item>
    <item>
      <title>Introduction to Toxicology for the Non-specialist</title>
      <description>
        <![CDATA[Li Kim Lee - Course participants will come away with practical knowledge to improve their understanding of the breadth of this fascinting subject. Discussed will be the role of toxicology in all stages of drug development, the regulatory environment under which toxicologists work, and]]>
      </description>
    </item>
    <item>
      <title>Adverse Event Reporting and Pharmacovigilance</title>
      <description>
        <![CDATA[Li Kim Lee - Recent times have proved to be the most turbulent in pharmacovigilance for many years. With million dollar fines, tougher guidelines and the introduction of MedDRA, it is crucial that you and your company reduce the risk of incorrect ADR reporting...now.]]>
      </description>
    </item>
    <item>
      <title>Adverse Event Reporting and Pharmacovigilance</title>
      <description>
        <![CDATA[Li Kim Lee - Recent times have proved to be the most turbulent in pharmacovigilance for many years. With million dollar fines, tougher guidelines and the introduction of MedDRA, it is crucial that you and your company reduce the risk of incorrect ADR reporting...now.]]>
      </description>
    </item>
    <item>
      <title>Advanced-level Adverse Event Reporting &amp; Pharmacovigilance</title>
      <description>
        <![CDATA[Li Kim Lee - The growing awareness of the size and severity of adverse drug reactions, especially with the global use of medicines, has highlighted the need to streamline adverse event reporting and get the right information in the right format as quickly as]]>
      </description>
    </item>
    <item>
      <title>Advanced-level Adverse Event Reporting &amp; Pharmacovigilance</title>
      <description>
        <![CDATA[Li Kim Lee - The growing awareness of the size and severity of adverse drug reactions, especially with the global use of medicines, has highlighted the need to streamline adverse event reporting and get the right information in the right format as quickly as]]>
      </description>
    </item>
    <item>
      <title>Medicine and Health</title>
      <description>
        <![CDATA[Helen Jaques - This group is for anyone with an interest in medicine and health, including clinicians, medical students, biomedical researchers and those simply curious about these topics. Let's use this group to discuss exciting research papers, medical stories in the news, issues]]>
      </description>
    </item>
    <item>
      <title>Shushil Choubey</title>
      <description>
        <![CDATA[Shushil Choubey - ]]>
      </description>
    </item>
    <item>
      <title>Regulatory Affairs for Phase I Clinical Trials</title>
      <description>
        <![CDATA[Li Kim Lee - Recent changes to the EU clinical trials directive have impacted on the time taken to gain regulatory approval in early clinical development. It is important to submit the relevant data and documentation in the correct format in order to proceed]]>
      </description>
    </item>
  </channel>
</rss>
